Home Overview Press Room Blog Publications For Students about us
Search

Personal genomics : Displaying 230-249 of 530


Test Your DNA for Diseases — No Doctor Requiredby Bonnie RochmanTimeOctober 23rd, 2012Even as physicians and bioethicists wrestle with the implications of whole-genome sequencing, companies like 23andMe are planning to make it available directly to the public.
Will My Son Develop Cancer? The Promise (and Pitfalls) of Sequencing Children’s Genomes by Bonnie RochmanTimeOctober 22nd, 2012Can you imagine wanting to know whether your newborn baby will fall victim to Alzheimer’s disease decades down the road? What about cancer or diabetes?
Personal Genomics in the Classroom: Students Sequence Themselvesby Monya BakerNature News BlogOctober 11th, 2012Medical and graduate students will get the chance to sequence and interpret their own genomes in what is being billed as the first-ever course to offer whole-genome sequencing.
Citing Privacy Concerns, U.S. Panel Urges End to Secret DNA Testingby Sharon BegleyReutersOctober 11th, 2012In response to companies that offer genome sequencing from such discarded items as cigarette butts, the President's bioethics commission stresses privacy concerns and suggests a ban on "surreptitious commercial testing."
Prenatal Test Presents Dilemmas to Expectant Mothersby Maureen SalamonUS NewsSeptember 28th, 2012Some women label information about fetal chromosomal abnormalities "toxic knowledge" they wish they hadn't received, a small new study shows.
Anatomy of a Webpage: Marketing Fetal Gene Tests and Sequenom’s MaterniT21by George EstreichBiopolitical Times guest contributorSeptember 24th, 2012In the age of genomics, whole-chromosome conditions are only the beginning. Our ability to sample fetal DNA from maternal blood means that not only Down syndrome, but before long any condition with a genetic component, any “risk,” can be forecast.
An API for Genome AppsThe Daily ScanSeptember 20th, 2012Direct-to-consumer gene test company 23andMe will allow third-party developers to create applications that piggyback on customers' personal genome data.
Potential Perils of DIY Genetic Testingby Anna SallehABC NewsSeptember 11th, 2012A new study adds to growing concern about the potential perils of direct-to-consumer genetic tests.
Yet Another Study Claims to Find Politics in Our Genes by Jessica CussinsBiopolitical TimesSeptember 6th, 2012A study on genes and political identity comes out just in time for the presidential election, but says little that’s new.
Bits of Mystery DNA, Far From ‘Junk,’ Play Crucial Roleby Gina KolataThe New York TimesSeptember 5th, 2012At least four million gene switches that reside in sections of the human genome once thought to be inactive turn out to have critical functions in the body, researchers reported.
Genes Now Tell Doctors Secrets They Can’t Utterby Gina KolataNew York TimesAugust 25th, 2012In laboratories around the world, genetic researchers using tools that are ever more sophisticated to peer into the DNA of cells are increasingly finding things they were not looking for.
Human Genes - Sold to the Highest Bidder?Federal Appeals Court Ruled that Myriad Can in Fact Patent Isolated Human Genes by Jessica CussinsBiopolitical TimesAugust 23rd, 2012A U.S. federal appeals court has reaffirmed that gene patents are legal in its ruling last week that Myriad Genetics can keep its patent on the BRCA1 and BRCA2 genes.
Who's Your Daddy? DNA Clinic Gives Answers, Sparks Concernsby Lily KuoReutersAugust 22nd, 2012A mobile DNA testing facility is raising questions about the ramifications of quick and easy tests to determine paternity and other biological connections.
Q & A on Myriad Decision: DNA Patent Upheld, Process Patent Notby Eryn BrownLos Angeles TimesAugust 17th, 2012Can a company patent a gene? According to a new appeals court ruling, yes — even when that gene is an isolated version of a gene that occurs in nature.
Researcher Accused of Misleading Pregnant Women by Sara ReardonNew ScientistAugust 9th, 2012A doctor at the Mount Sinai School of Medicine has been prescribing a controversial drug to pregnant women to treat a rare genetic disorder in female fetuses.
23andMe Wants FDA Approval for Personal DNA Testing. What Can It Reveal?by Bonnie RochmanTIME HealthlandAugust 2nd, 2012The personal genomics company 23andMe announced that it is seeking FDA approval for its version of DNA testing.
Euroscience Open Forum 2012: DNA Gene Testing 'Will Screen Out Lovers'by Telegraph ReportersThe TelegraphJuly 13th, 2012A British professor has suggested that couples will soon be able to choose their life partner solely based on the compatibility of their genes instead of through love.
European Scientists on Direct-to-Consumer Gene Tests: Thumbs Downby Marcy DarnovskyBiopolitcal TimesJuly 13th, 2012Two scientific advisory groups warn that direct-to-consumer gene testing “has little clinical value” and the “potential to be harmful.”
DNA Match Tying Protest to 2004 Killing Is Doubtedby Willam Rashbaum and Joesph GoldsteinThe New York TimesJuly 11th, 2012An alleged DNA link between the 2004 murder of a Juilliard student and a chain placed around an Occupy Wall Street protest in March is likely a laboratory error, experts say.
Survival of the Fastest?by Pete ShanksBiopolitical TimesJuly 10th, 2012Michael Johnson, the legendary athlete, recently made global headlines for suggesting that black American and Caribbean sprinters have a "superior athletic gene."
Displaying 230-249 of 530  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1936 University Ave, Suite 350, Berkeley, CA 94704 • • (p) 1.510.665.7760 • (F) 1.510.665.8760